Andrew L. Tussing
Chief Operating Officer, Treasurer & Corporate Secretary
- History & Future
- Vaccinogen Timeline
- Chairman's Letter
- What is OncoVAX®?
- Driving Principles
- Management
- Facilities
- Publications
Mr. Tussing has been involved in the founding and building of businesses throughout most of his career. A co-founder of Vaccinogen, he raised the needed capital to launch Vaccinogen. Mr. Tussing has also been leading the effort of launching Vaccinogen's operations and is preparing the Company's commercialization of OncoVAX®. Most recently, Mr. Tussing has been active in investment banking activities at 1st BridgeHouse Securities and as Managing Director of Growth5 – a venture capital marketing strategy firm that helps companies maximize their growth potential.
Prior to that, Mr. Tussing was a co-founder of Milestone International Asset Management which developed hedge-fund-related solutions for financial advisors. He raised capital for firm operations and established key relationships for Milestone both on the customer and strategic partnership levels. Previously, Mr. Tussing served in senior roles at Pershing, a division of the Bank of New York, and Deutsche Bank’s Alex. Brown division where he was Director of Strategic Development, Marketing & Sales for its Correspondent Services business.
He co- founded TM Resources, which provided strategy, management and marketing consulting services for a variety of securities brokerage firms and clearing/custody banks.
Early in his career, Mr. Tussing had the rare opportunity to help develop a completely new and autonomous business within America’s oldest investment bank - Alex. Brown Incorporated – and was key to growing it to over $60 million in revenues within eight years.